Streetbeat News

Regulatory

TLSA

Tiziana Life Sciences shares are trading higher after the company was granted Fast Track designation for its intranasal formulation of foralumab by the FDA.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 11:04 am

TLSA

Tiziana Life Sciences has been granted FDA Fast Track designation for its intranasal formulation of Foralumab, a significant milestone that could expedite the development and review process of the drug.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 11:04 am

LLY

NVO

PFE

RHHBY

Novo Nordisk's stock dipped 1.25% in pre-market trading despite the UK approving its weight loss drug, Wegovy, for reducing heart complications in overweight adults. Increased competition from Pfizer and Roche in the weight loss drug market also contributed to the decline.

Portfolio Pulse from Benzinga Neuro

July 24, 2024 | 10:57 am

EMLDU

Trading in EMLDU has been halted as of 6:55:00 a.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:55 am

EMLDW

Trading in EMLDW has been halted as of 6:55:00 a.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:55 am

EMLD

Trading in EMLD was halted at 6:55:00 a.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:55 am

NKTX

Nkarta has initiated an investigator-sponsored trial of NKX019, a CD19-directed chimeric antigen receptor NK-cell therapy for systemic lupus erythematosus. Additionally, in June 2024, Nkarta initiated the NTRUST-1 Phase 1 trial of NKX019 for lupus nephritis.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:07 am

GM

TSLA

General Motors (GM) has halted the development of its Origin autonomous vehicle, citing regulatory concerns, but Tesla CEO Elon Musk claims the real reason is GM's technological shortcomings. GM will now focus on the next-generation Chevrolet Bolt for its Cruise unit's autonomous operations. Cruise co-founder Kyle Vogt expressed disappointment, accusing GM of abandoning innovative projects prematurely.

Portfolio Pulse from Anan Ashraf

July 24, 2024 | 10:03 am

AAPL

NVDA

TSM

Japan's Prime Minister Fumio Kishida announced a new bill to boost domestic investment in AI and semiconductor production. The bill aims to support research, development, and large-scale production of next-generation chips, particularly through Rapidus Corp. This move is part of Japan's strategy to triple its domestic semiconductor sales by 2030 and diversify its chip supply chain. The announcement comes amid global semiconductor rivalry, particularly between the U.S. and China. Major tech companies like Nvidia and Apple, which rely on TSMC for chips, could be impacted by these developments.

Portfolio Pulse from Benzinga Neuro

July 24, 2024 | 9:40 am

AAPL

EWP

Spain's CNMC has announced an investigation into Apple for potential anti-competitive practices related to the App Store.

Portfolio Pulse from charles@benzinga.com

July 24, 2024 | 9:00 am